Reprint
Drug Treatments for Inflammatory Bowel Diseases
Edited by
January 2024
202 pages
- ISBN978-3-0365-9976-2 (Hardback)
- ISBN978-3-0365-9975-5 (PDF)
This book is a reprint of the Special Issue Drug Treatments for Inflammatory Bowel Diseases that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
We are pleased to inform you that the Special Issue reprint “Drug Treatments for Inflammatory Bowel Diseases” has been published online and is freely accessible on the MDPI Books platform. We hope that the reprint meets the reader's expectations in the field and further promotes investigations into the treatment of IBD by the scientific community.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
Ren-Shen-Bai-Du Powder (RSBDP); inflammatory bowel disease; network pharmacology; molecular docking; underlying mechanism; inflammatory bowel disease; cytokines; lymphocyte homing; inflammatory bowel disease; Crohn’s Disease; MK2; MAPKAPK2; checkpoint molecules; Lag3; PD-L1; matrix metalloproteinases (MMPs); diabetes mellitus; inflammatory bowel disease; pharmacoepidemiology; pioglitazone; Taiwan; inflammatory bowel disease; vedolizumab; treatment outcome; 5-ASA; anti-TNF; gene expression; Crohn’s disease; ulcerative colitis; inflammatory bowel disease; miR-497a-5p; TGF-β; macrophage; Crohn’s disease; inflammatory bowel disease; pharmacoepidemiology; rosiglitazone; Taiwan; type 2 diabetes mellitus; ulcerative colitis; ulcerative colitis; ketone esters; (R,R)-BD-AcAc2; NLRP3 inflammasome; pyroptosis; autophagy; gut dysbiosis; IBD; ulcerative colitis; Crohn’s disease; oxidative stress; ROS; Crohn’s disease; ulcerative colitis; 5-ASA; corticosteroid; immunomodulator; biological therapy; JAK; s1P; n/a